62 results
CORRESP
CYCN
Cyclerion Therapeutics Inc
12 Dec 23
Correspondence with SEC
12:00am
a majority ownership; one CEO director was elected by the common stockholders, which is Peter M. Hecht1; and the remaining two independent directors were … designated by agreement of a majority of the other then serving directors. Cyclerion does not have the right to nominate any director.
As noted above
8-K
xpibxfs7v7f4ceyqd
19 Jul 23
Submission of Matters to a Vote of Security Holders
5:27pm
DEFM14A
98lu pnwwq
20 Jun 23
Proxy related to merger
4:55pm
PREM14A
84845pqvwfgep
9 Jun 23
Preliminary proxy related to merger
5:23pm
DEFA14A
uzx04n ouqluy7fu7v
11 May 23
Additional proxy soliciting materials
7:28pm
8-K
EX-2.1
6lchc9
11 May 23
Cyclerion Announces Definitive Agreement for Zagociguat and CY3018
7:26pm
8-K
yd9rarri
11 May 23
Cyclerion Announces Definitive Agreement for Zagociguat and CY3018
7:26pm
8-K
EX-99.2
z44jyc y1rnp6s7nw40
28 Jul 22
Cyclerion Therapeutics Announces Positive Topline Clinical Data for CY6463 in
9:00am
424B4
y7qb3ipnpry 3zu1
24 Jun 21
Prospectus supplement with pricing info
10:33am